Novo Nordisk says it has filed a complaint with Health Canada regarding the promotion and sale of compounded semaglutide – a key ingredient in both Ozempic and Wegovy.

Unlike GLP-1 receptor agonists like Ozempic, compound 15 doesn't suppress appetite or lead to muscle loss, which means it may be safer in that regard too.

Health Canada has issued a recall notice for compounded drugs containing semaglutide, which is a key component in popular medications like Ozempic and Wegovy.

Compounded GLP-1s often differ in formulation, dosage strength and delivery method compared to FDA-approved drugs like Ozempic or Wegovy.

GLP-1 drugs bought online or at compound pharmacies could cause harm, according to Tennessee Attorney General Jonathan Skrmetti.

Doctors say the situation forces them to get creative in treating patients, but there’s hope that prices may fall more in the future.

The contents of PBPs of intravenous contrast media (or PBPs of any medication) should only be transferred to single-dose containers or syringes in the pharmacy under a laminar flow hood or other ...